| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/13/2004 | US20040092528 Brain disorders; psychological disorders; Alzheimer's disease; Parkinson's disease; schizophrenia |
| 05/13/2004 | US20040092526 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092525 Pirazino(aza)indole derivatives |
| 05/13/2004 | US20040092524 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same |
| 05/13/2004 | US20040092523 Method for the treatment of heart failure |
| 05/13/2004 | US20040092522 Synergistic combinations |
| 05/13/2004 | US20040092520 Purine compounds and uses thereof |
| 05/13/2004 | US20040092519 New treatment for hot flashes |
| 05/13/2004 | US20040092518 Compounds for the treatment of metabolic disorders |
| 05/13/2004 | US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 05/13/2004 | US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
| 05/13/2004 | US20040092511 Mixture containing antiserotonine agents |
| 05/13/2004 | US20040092510 Novel 2, 3 - benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
| 05/13/2004 | US20040092509 Controlling dosage times |
| 05/13/2004 | US20040092508 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 05/13/2004 | US20040092507 Melanocortin receptor agonists |
| 05/13/2004 | US20040092506 Administering estrogen antagonist; skin disorders; wrinkle resistance; antiarthritic agents; anticancer agents; wound healing agents |
| 05/13/2004 | US20040092505 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 05/13/2004 | US20040092504 Definitive medications for treating fibromyalgia |
| 05/13/2004 | US20040092503 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/13/2004 | US20040092502 Central nervous system disorders; dietetics; psychological disorders; sleep disorders; sexual disorders |
| 05/13/2004 | US20040092501 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 05/13/2004 | US20040092500 Methods and therapeutic combinations for the treatment of demyelination |
| 05/13/2004 | US20040092499 Methods and therapeutic combinations for the treatment of autoimmune disorders |
| 05/13/2004 | US20040092498 Substituted glycine derivatives for use as medicaments |
| 05/13/2004 | US20040092497 Heteroarylakanoic acids as intergrin receptor antagonists |
| 05/13/2004 | US20040092496 Anticancer agents; destroying cancer, warts |
| 05/13/2004 | US20040092495 Hypoglycemic agents; antidiabetic agents |
| 05/13/2004 | US20040092494 Method of increasing testosterone and related steroid concentrations in women |
| 05/13/2004 | US20040092493 Method for ameliorating male erectile dysfunction |
| 05/13/2004 | US20040092492 Reacting a corresponding aldehyde with hydroxylamine compound forming oxime group |
| 05/13/2004 | US20040092491 Acute respiratory system disorders |
| 05/13/2004 | US20040092490 Substituted tetracycline compounds for the treatment of malaria |
| 05/13/2004 | US20040092489 Polysubstituted indan-1-ol compounds, and methods for their preparation and use |
| 05/13/2004 | US20040092488 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 05/13/2004 | US20040092487 Inhibitors of epoxide hydrolases for the treatment of hypertension |
| 05/13/2004 | US20040092483 Aqueous solution |
| 05/13/2004 | US20040092482 Antiaging; aqueous solution containing hydroxyacid |
| 05/13/2004 | US20040092481 Eating disorders; irritable bowel disorders; headaches; obsessive compulsive disorders |
| 05/13/2004 | US20040092480 Factor x inhibitors; antocoagulants; thrombosis therapy; diphenylamidine compound in binder |
| 05/13/2004 | US20040092479 Composition and method for treatment and prevention of traumatic synovitis and damage to articular cartilage |
| 05/13/2004 | US20040092478 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 05/13/2004 | US20040092477 Compositions for the treatment and prevention of arterial thrombosis and use of an inhibitor of factor Xa alone and/or in combination with an anti-platelet aggregation agent |
| 05/13/2004 | US20040092473 Method for nucleic acid transfection of cells |
| 05/13/2004 | US20040092470 Dry powder oligonucleotide formualtion, preparation and its uses |
| 05/13/2004 | US20040092459 Novel macrolides |
| 05/13/2004 | US20040092458 Administering a Free-B-Ring flavonoid as cyclooxygenase-2 (COX-2) inhibitor to treat osteoarthritis, rheumatoid arthritis, menstrual cramps, Systemic Lupus Erythromatosis, psoriasis, migraines, inflammatory bowel disease, cancer |
| 05/13/2004 | US20040092455 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 05/13/2004 | US20040092454 3-biphenyl-4-yl-3-(2-(4-(pyridin-2-ylamino)pentanoylamino)-pen tanoyl amino)propionic acid derivatives |
| 05/13/2004 | US20040092453 Synergistic antineoplastic effect; side effect reduction |
| 05/13/2004 | US20040092449 Administering a luminal cholecystokinin releasing factor polypeptide; treating obesity |
| 05/13/2004 | US20040092438 Antiischemic agents; brain disorders; ganglioside antagonist |
| 05/13/2004 | US20040092436 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins |
| 05/13/2004 | US20040092433 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/13/2004 | US20040092431 Therapy for vision defects |
| 05/13/2004 | US20040092428 Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof |
| 05/13/2004 | US20040092427 Method and composition for treating alzheimer's disease and dementias of vascular origin |
| 05/13/2004 | US20040092007 Allelic growth differentiation factor-9b (GDF-9B) for treatment annd prevention of sex disorders; in vitro fertilization; artificial insemination; veterinary medicine |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/13/2004 | US20040091890 Life sciences business systems and methods |
| 05/13/2004 | US20040091878 Zinc finger domain recognition code and uses thereof |
| 05/13/2004 | US20040091559 Compositions for diabetes treatment and prophylaxis |
| 05/13/2004 | US20040091556 For topical application and saturation of portions of sinus physiology, for therapy of cold or flu |
| 05/13/2004 | US20040091554 Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors |
| 05/13/2004 | US20040091551 Topical composition and application system |
| 05/13/2004 | US20040091545 Entrapping the acid in a methacrylic acid copolymer by acidifying a basic solution or dispersion to cause formation of a precipitate which is then collected and dried; odorless dietary supplement for cardio-vascular systems |
| 05/13/2004 | US20040091542 Method for the preparation of nanoparticles |
| 05/13/2004 | US20040091540 Method for restoring a damaged or degenerated intervertebral disc |
| 05/13/2004 | US20040091539 A topical composition in the form of a solid stick comprising a corticosteroid, petrolatum, a wax, propylene glycol, and an emulsifier; an outer protective covering being constructed to prevent hand contact; anhydrous; skin disorders |
| 05/13/2004 | US20040091536 Stability of masking of the taste when the reconstitutable, dry suspension contains granules having a core of drug and excipients (thickener, preservative and buffer) and at least three successive layers of coating; organoleptic |
| 05/13/2004 | US20040091535 Coated tablets |
| 05/13/2004 | US20040091534 Once-daily administrations characterised by a high degree of absorption using pellets comprising a powder mixture of drug, acid/base excipients and diluent surrounded by a multilayer membrane of water soluble and insoluble polymers to control |
| 05/13/2004 | US20040091532 One-a-day, oral administration of a methylphenidate drug, e,g, Ritalin, the dosage of which form provides an immediate dose upon ingestion followed by release of more dose(s) later; particles uncoated/coated with ammonio methacrylate |
| 05/13/2004 | US20040091531 Modified release of an insulin sensitizer and a pharmaceutically acceptable carrier; sustained release; time-release agents; pulsation; enteric tablets; hypoglycemic agents, pioglitazone or troglitazone; Type 2 diabetes |
| 05/13/2004 | US20040091530 Dosage forms for oral admistration resulting in a maximum secretagogue plasma concentration, Cmax, less than 80% Cmax of that when an equal dose is administered in an immediate release form; osmotic tablet of a asymetric membrane; 6 hours |
| 05/13/2004 | US20040091529 Methods and dosage forms for increasing solubility of drug compositions for controlled delivery |
| 05/13/2004 | US20040091527 Method of increasing the bioavailability and tissue penetration of azithromycin |
| 05/13/2004 | US20040091526 A graphic art marking of a pregnant women, is used to prevent erroneous dispensing of or erroneous ingestion of drugs not intended for pregnant women, improve patient compliance, product effectiveness |
| 05/13/2004 | US20040091525 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase B inhibitor component |
| 05/13/2004 | US20040091523 Pharmaceutical composition and the process for its preparation |
| 05/13/2004 | US20040091521 Multilayer backing construction for active substance patch systems |
| 05/13/2004 | US20040091518 Lysine mixture and apparatus and method for administering lysine |
| 05/13/2004 | US20040091516 Printing or dispensing a suspension such as three-dimensional printing of dosage forms |
| 05/13/2004 | US20040091509 Skin care composition that mediates cell to cell communication |
| 05/13/2004 | US20040091508 Rapidly absorbed liquid compositions |
| 05/13/2004 | US20040091507 Rapidly absorbed liquid compositions |
| 05/13/2004 | US20040091506 Topical antifungal treatment |
| 05/13/2004 | US20040091493 Active ingredient such as specified plant extract(s) or calcium compound that does not cause any inflammatory, irritation or intolerance reactions; tissue models for drug screening for drugs against skin disorders; dandruff, acne |
| 05/13/2004 | US20040091485 Humanised antibodies to the epidermal growth factor receptor |
| 05/13/2004 | US20040091484 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/13/2004 | US20040091477 Immunophilin-binding compound and ginkgolide compound |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091465 Endostatin combined with sucrose octasulfate |
| 05/13/2004 | US20040091455 Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration |
| 05/13/2004 | US20040091454 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration |
| 05/13/2004 | US20040091450 Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body |
| 05/13/2004 | US20040091448 Disinfecting dip compositions and related methods |
| 05/13/2004 | US20040091442 Polyamino acid derivatives and use thereof in compositions for treating keratin fibers |
| 05/13/2004 | US20040091433 Chromene derivative |